Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Label-Free Array Systems Market Size Forecast: How Big Could The Market Get By 2030?
The label-free array systems market has demonstrated robust expansion in recent years. It is anticipated to increase from $1.48 billion in 2025 to $1.59 billion in 2026, at a compound annual growth rate (CAGR) of 7.6%. The historical surge in this market can be linked to factors such as the restricted availability of label-free platforms, the reliance on traditional labeling techniques, an uptick in pharmaceutical research and development, the growth of academic and research institutes, and the embrace of conventional biosensors.
The label-free array systems market is anticipated to experience substantial expansion in the coming years, growing to $2.1 billion in 2030 at a compound annual growth rate (CAGR) of 7.2%. This projected expansion over the forecast period is propelled by developments in surface plasmon resonance and bio-layer interferometry, increased uptake by contract research organizations (CROs), an escalating need for highly efficient and automated systems, a heightened emphasis on kinetics and affinity mapping, and the incorporation of artificial intelligence and big data analytics. Key trends during this period encompass the wider embrace of label-free detection techniques, a surging requirement for analyzing molecular interactions in real time, the incorporation of advanced high-throughput screening features, expanded application in drug discovery and protein-protein interaction research, and a sharpened focus on improving the sensitivity and precision of assays.
Get A Free Sample Report With In-Depth Market Insights:
Label-Free Array Systems Market Growth Momentum: What Factors Are Shaping Demand?
The escalating threat of lifestyle-related chronic diseases is projected to propel the expansion of the label-free array systems market in the coming years. These long-term conditions are primarily caused by unhealthy behaviors such as poor diet, insufficient physical activity, smoking, and excessive alcohol consumption. The rise in lifestyle-related chronic diseases is linked to increasing sedentary lifestyles, as more individuals engage in desk-bound professions and screen-based leisure activities, reducing physical movement and negatively affecting metabolic health. Label-free array systems are advanced biosensing technologies designed for real-time, high-throughput detection of biomolecular interactions without the use of fluorescent or radioactive labels. These systems are becoming increasingly crucial in mitigating the risk of lifestyle-related chronic diseases by enabling early detection, risk assessment, and personalized prevention strategies. For instance, a report from April 2025 by the Centers for Disease Control and Prevention, a US-based federal government agency, indicated that in 2023, 76.4% (representing 194 million) of US adults reported one or more chronic conditions, including 59.5%, 78.4%, and 93.0% of young, midlife, and older adults, respectively. Additionally, 51.4% (representing 130 million) of US adults reported multiple chronic conditions (MCC), comprising 27.1%, 52.7%, and 78.8% of young, midlife, and older adults, respectively. Therefore, the growing risk of lifestyle-related chronic diseases will further stimulate the growth of the label-free array systems market.
Label-Free Array Systems Market Segments: Where Is Growth Concentrated?
The label-free array systems market covered in this report is segmented –
1) By Technology: Surface Plasmon Resonance, Bio Layer Interferometry, Cellular Dielectric Spectroscopy, Other Technologies
2) By Accessories: Sensor Chips, Reagents, Consumables, Other Accessories
3) By Application: Drug Discovery, Protein-Protein Interactions, Receptor Ligand Assays, Thermodynamics, Kinetics Or Affinity Mapping, Other Applications
4) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Research Organizations, Other End Users
Subsegments:
1) By Surface Plasmon Resonance: Imaging SPR, SPR Microscopy, Multi-Parametric SPR, Localized SPR
2) By Bio Layer Interferometry: Fiber Optic-Based BLI, Plate-Based BLI, High-Throughput BLI Systems
3) By Cellular Dielectric Spectroscopy: Real-Time Impedance-Based Systems, Multi-Well Plate CDS Platforms, Label-Free Cytotoxicity Assays
4) By Other Technologies: Microcantilever-Based Systems, Optical Waveguide Grating Sensors, Quartz Crystal Microbalance (QCM), Field-Effect Transistor (FET)-Based Biosensors
Label-Free Array Systems Market Trends Redefining Industry Growth
Major companies within the label-free array systems market are concentrating on developing advanced solutions, including label-free biosensors, to simplify the testing process. Label-free biosensors are analytical devices designed to directly detect biological interactions without the need for fluorescent or radioactive tags. For instance, in February 2024, SPOC Proteomics Inc., a US-based life science company, launched its customizable SPOC protein biosensor chips. This innovation offers real-time, label-free biosensing for up to 1,000 fully folded proteins on a small 1.5 cm² SPR chip. It utilizes a unique technique that produces proteins directly from DNA in tiny nanoliter wells while simultaneously capturing and purifying these proteins on the sensor surface. This approach circumvents the traditional recombinant protein production process, leading to cost reductions of 10 to 100 times compared to standard methods. Moreover, SPOC protein biosensor chips uniquely provide extensive qualitative, quantitative, and kinetic data, making them ideal for high-throughput proteomic studies.
Label-Free Array Systems Market Key Participants And Competitive Landscape
Major companies operating in the label-free array systems market are Merck KGaA, Thermo Fisher Scientific Inc, Agilent Technologies Inc, Cytiva, PerkinElmer Inc, Sartorius AG, Bruker Corporation, Horiba Instruments Incorporated, Malvern Panalytical Ltd, Reichert Inc, Attana AB, NanoSPR Devices, BioNavis Ltd, Biosensing Instrument Inc, GeSiM Co, Plexera LLC, Plasmetrix, Nicoya Lifesciences Inc, Creoptix AG, Sierra Sensors GmbH
View The Full Label-Free Array Systems Market Report:
Label-Free Array Systems Market Geographic Analysis: Where Is Demand Rising Fastest?
North America was the largest region in the label-free array systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the label-free array systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model








